GGrantIndex
Sort

326,823 grants matching clinical trial

HIV VACCINES TRIAL UNITS

$1,865,844
Fred Hutchinson Cancer Research Center · U01 · FY2003 · AI

Antibody-based Contraceptive MPTs: Advancing the Human Contraceptive Antibody (HCA) through Clinical Trials

$1,865,710
Deborah J Anderson · Boston University Medical Campus · P50 · FY2024 · HD

PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: UNIVERSITY OF WISCONSIN

$1,865,644
University Of Wisconsin System · · FY2022 · Defense Health Agency

Administrative Core

$1,865,582
Rima F Kaddurah-Daouk · Duke University · U19 · FY2019 · AG

Treating mild cognitive impairment with transcranial direct current stimulation

$1,865,498
Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R01 · FY2021 · AG

Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies

$1,865,468
Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$1,865,407
Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

$1,865,350
Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA

Immunotherapy for Malignant Mesothelioma and Lung Cancer

$1,865,336
Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Disease Model Development and Phenotyping Project

$1,865,091
Grant R Macgregor · University Of California-Irvine · U54 · FY2019 · AG

Emory University Lung Cancer SPORE

$1,865,070
Suresh S Ramalingam · Emory University · P50 · FY2020 · CA

A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION

$1,864,898
Laurie Sower · Chrysalis Biotherapeutics, Inc. · N01 · FY2019 · AI

NORMAL & NEOPLASTIC GROWTH IN THE BRAIN

$1,864,889
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2025 · CA

NORMAL & NEOPLASTIC GROWTH IN THE BRAIN

$1,864,889
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2023 · CA

AFE inhibitor combinations as HIV1 topical microbicides

$1,864,885
Weill Medical College Of Cornell Univ · U19 · FY2005 · AI

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$1,864,880
Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG

Commercializing CivaSheet for Pancreatic Cancer Patients

$1,864,846
Kristy Perez · Civatech Oncology, Inc. · R44 · FY2023 · CA

Healthy Aging and Senile Dementia

$1,864,797
John Morris · Washington University · P01 · FY2016 · AG

Pharmacogenetics of Asthma Treatment

$1,864,564
Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2013 · HL

TOBACCO EXPOSURE REDUCTION

$1,864,489
University Of Minnesota Twin Cities · P50 · FY2001 · DA

Autism Adaptive Community-based Treatment to Improve Outcomes using Navigators (ACTION) Network

$1,864,378
Amy M Wetherby · Florida State University · R01 · FY2021 · HD

1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)

$1,864,327
Manesh R Patel · Duke University · UH3 · FY2025 · HL

ADULT AIDS CLINICAL TRIALS UNIT (AACTU)

$1,864,184
University Of Rochester · U01 · FY2002 · AI

Targeting galectin-3 to overcome insulin resistance in type 2 diabetes

$1,864,171
Hafiz Ahmed · Glycomantra, Inc. · R44 · FY2024 · DK

Aurora NCORP Community Site

$1,863,995
Thomas J Saphner · Aurora Health Care, Inc. · UG1 · FY2021 · CA